Entries of Hofheinz, R. D. on the publication server

Fokas, E., Allgäuer, M., Polat, B., Klautke, G., Grabenbauer, G., Fietkau, R., Kuhnt, T., Staib, L., Brunner, T., Grosu, A. L., Schmiegel, W., Jacobasch, L., Weitz, J., Folprecht, G., Schleska-Lange, A., Grützmann, R., Schwarzbach, M., Paolucci, V., Bechstein, W. O., Friede, T., Ghadimi, M., Hofheinz, R. D. and Rödel, C. (2019) OC-0501 Chemo-RT plus induction or consolidation chemotherapy for rectal cancer: a randomised phase 2 trial. Radiotherapy and Oncology 133, S257-S258. Fulltext not available.

Al-Batran, S.-E., Pauligk, C., Hofheinz, R. D., Lorenzen, S., Wicki, A., Siebenhuener, A. R., Schenk, M., Thuss-Patience, P. C., Kretzschmar, A., Bolling, C., Eigendorff, E., Angermeier, S., Pink, D., Geissler, M., Goekkurt, E., Schmalenberg, H., Waberer, L., Talbot, J. J., Goetze, T. O. and Homann, N. (2019) Perioperative atezolizumab in combination with FLOT versus FLOT alone in patients with resectable esophagogastric adenocarcinoma: DANTE, a randomized, open-label phase II trial of the German Gastric Group of the AIO and the SAKK. Annals of Oncology 30 (Suppl5), v324. Fulltext not available.